Chang Chu et al, J. Med. Chem. 32: 612-617 1989. |
De Clercg, Methods and Findings in Experimental and Clinical Pharmacology, vol. 2, No. 5 (1980). |
Widell et al, Antiviral Res., 6(2), 103-12 (1986). |
De Clercq, Mol. Pharmcol., 19(1), 122-9 (1981). |
Robin, C & EN, Jan. 27, 1986. |
Ruth et al. "C-5 Substituted Pyrimidine Nucleosides. 1. Synthesis of C-5 Allyl, Propzl, and Propenyl Uracil and Cystosine Nucleosides via Organopalladium Intermediates" J. Org. Chem., vol. 43, No. 14 (1978). |
Balzarini et al. "5-Substituted 2'-Deoxyuridines: Correlation Between Inhibition of Tumor Cell Growth and Inhibition of Thymidine Kinase and Thymidylate Synthetase", Biological pharmacology, vol. 31, No. 22: 3673-3682 (1982). |
De Clercq et al., "Nucleoside Analogs with Selective Antiviral Activity", J. Carbohydrates Nucleosides-Nucheotides, vol. 5, No. 3: 187-224 (1978). |
Tao et al., J. Medical Virology, "Inhibition of Human Hepatitus B Virus DNA Polymerase and Duck Hepatitus B Virus Polymerase by Triphosphatis of Triphosphates of Thymidine Analogs and Pharmacokinatic Properties of the Corresponding Nucleosides". |
Nordenfelt et al., J. Medical Virology, 22: 231-36 (1987). |
Vrang et al., Antimicrobial Agents and Chemotherapy, p. 867-872 (May 1986) vol. 29, No. 5. |
Oberg, "Antiviral Therapy", IV International Conference on AIDS, Stockholm 1988, AIDS Research in Press. |
I. Basnak et al.: Coll. Czech. Chem. Commun. 51(8) 1986, pp. 1764-1771. |
A. Holy et al.: Nucleic Acids Research Symp. Ser. No. 18, 1987, pp. 69-73. |
E. DeClerq et al.: J. Med. Chem. 26(5), 1983, pp. 661-666. |